Tatva Chintan Pharma Chem Limited
National Stock Exchange of IndiaTotal Valuation
Tatva Chintan Pharma Chem Limited carries a market capitalization of 29.37B, placing it among publicly traded companies globally. Its enterprise value stands at 25.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 29.37B |
| Enterprise Value | 25.73B |
Share Statistics
Tatva Chintan Pharma Chem Limited currently has 23.39M shares outstanding.
| Shares Outstanding | 23.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tatva Chintan Pharma Chem Limited trades at a trailing price-to-earnings ratio of 58.54. The price-to-sales ratio is 4.87, and the price-to-book ratio stands at 105.25.
| PE Ratio | 58.54 |
| PS Ratio | 4.87 |
| PB Ratio | 105.25 |
| P/TBV Ratio | 3.18 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tatva Chintan Pharma Chem Limited trades at an EV/EBITDA multiple of 45.70 and an EV/FCF ratio of 1,223.56. The EV/Sales ratio of 5.09 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 45.70 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.09 |
| EV / EBITDA | 45.70 |
| EV / EBIT | 45.70 |
| EV / FCF | 1,223.56 |
Financial Position
Tatva Chintan Pharma Chem Limited maintains a current ratio of 1.64, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.40, indicating elevated leverage, while an interest coverage ratio of 19.75 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.64 |
| Quick Ratio | 0.04 |
| Debt / Equity | 15.40 |
| Debt / EBITDA | 2.14 |
| Interest Coverage | 19.75 |
Financial Efficiency
Tatva Chintan Pharma Chem Limited posts a return on equity of 23.67 and a return on invested capital of 4.95.
| Return on Equity (ROE) | 23.67 |
| Return on Assets (ROA) | 4.57 |
| Return on Invested Capital (ROIC) | 4.95 |
| Return on Capital Employed (ROCE) | 17.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.36 |
Taxes
Over the trailing twelve months, Tatva Chintan Pharma Chem Limited has paid 149.55M in income taxes, reflecting an effective tax rate of 26.23.
| Income Tax | 149.55M |
| Effective Tax Rate | 26.23 |
Stock Price Statistics
Tatva Chintan Pharma Chem Limited's stock has gained approximately 31.55192% over the past 52 weeks. The 50-day moving average sits at 1,227.44, while the 200-day moving average is 1,261.58.
| Beta (5Y) | N/A |
| 52-Week Price Change | 31.55192% |
| 50-Day Moving Average | 1,227.44 |
| 200-Day Moving Average | 1,261.58 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tatva Chintan Pharma Chem Limited generated 5.06B in revenue and converted that into 420.54M in net income, yielding earnings per share of 17.98. EBITDA reached 563.11M, while operating income came in at 563.11M.
| Revenue | 5.06B |
| Gross Profit | 2.81B |
| Operating Income | 563.11M |
| Pretax Income | 570.09M |
| Net Income | 420.54M |
| EBITDA | 563.11M |
| EBIT | 563.11M |
| Earnings Per Share (EPS) | 17.98 |
Balance Sheet
Tatva Chintan Pharma Chem Limited holds 91.46M in cash and equivalents against 1.20B in total debt, resulting in a net debt position of 1.15B. Total book value stands at 233.92M, with working capital of 1.36B providing operational flexibility.
| Cash & Cash Equivalents | 91.46M |
| Total Debt | 1.20B |
| Net Debt | 1.15B |
| Equity (Book Value) | 233.92M |
| Book Value Per Share | 10.00 |
| Working Capital | 1.36B |
Margins
Tatva Chintan Pharma Chem Limited operates with a gross margin of 55.61, reflecting its pricing power and cost economics. The operating margin of 11.13 and net profit margin of 8.31 provide insight into operational efficiency.
| Gross Margin | 55.61 |
| Operating Margin | 11.13 |
| Pretax Margin | 11.27 |
| Profit Margin | 8.31 |
| EBITDA Margin | 11.13 |
Scores
Tatva Chintan Pharma Chem Limited posts an Altman Z-Score of 7.51, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.51 |